Infection Control

Federal officials reduce number of expected H1N1 vaccines

Infection Control Weekly Monitor, August 19, 2009

Want to receive articles like this one in your inbox? Subscribe to Infection Control Weekly Monitor!

Last week federal officials cut back their original estimate of H1N1 flu vaccine doses expected in October by more than half, according to CIDRAP.

Originally a federal immunization advisory panel planned to release 120 million doses in October and then 80 million each month thereafter. Now they are estimating 45 million doses by October and 20 million doses per week after that, said Dr. Robin Robinson, director of the Biological Advanced Research and Development Authority (BARDA) at the U.S. Department of Health and Human Services (HHS) during a National Biodefense Safety Board teleconference.

Several reasons have contributed to the setback, including a slow vaccine delivery from manufacturers. Some sites are just completing seasonal flu vaccine production and have limited fill-and-finish sites, according to the article. Other companies, including CSL Biotherapies in Australia, have a contractual commitment to produce vaccines for their home country first. Still others are behind in seasonal flu production, delaying H1N1 vaccine production.



Want to receive articles like this one in your inbox? Subscribe to Infection Control Weekly Monitor!

Most Popular

Related Articles